Leisure
Build Your Comparison
Side-by-side financial analysisStock Comparison
ESCA vs MCRI vs JPM vs DKNG vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Gambling, Resorts & Casinos
Banks - Diversified
Gambling, Resorts & Casinos
Banks - Diversified
ESCA vs MCRI vs JPM vs DKNG vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Leisure | Gambling, Resorts & Casinos | Banks - Diversified | Gambling, Resorts & Casinos | Banks - Diversified |
| Market Cap | $256M | $2.31B | $896.00B | $14.38B | $422.78B |
| Revenue (TTM) | $240M | $545M | $280.33B | $6.29B | $191.57B |
| Net Income (TTM) | $15M | $101M | $57.05B | $59M | $30.51B |
| Gross Margin | 27.1% | 53.0% | 60.0% | 41.8% | 56.1% |
| Operating Margin | 8.7% | 23.4% | 25.9% | 0.6% | 19.7% |
| Forward P/E | 17.3x | 19.5x | 14.4x | 122.9x | 12.6x |
| Total Debt | $20M | $26M | $942.38B | $1.93B | $365.90B |
| Cash & Equiv. | $12M | $96M | $343.34B | $1.60B | $231.84B |
ESCA vs MCRI vs JPM vs DKNG vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Escalade, Incorpora… (ESCA) | 100 | 133.5 | +33.5% |
| Monarch Casino & Re… (MCRI) | 100 | 378.6 | +278.6% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| DraftKings Inc. (DKNG) | 100 | 87.2 | -12.8% |
| Bank of America Cor… (BAC) | 100 | 235.9 | +135.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ESCA vs MCRI vs JPM vs DKNG vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ESCA is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 0.87, yield 3.2%, current ratio 4.28x
- 3.2% yield, vs JPM's 1.9%, (1 stock pays no dividend)
MCRI carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 5.2% 10Y total return vs JPM's 465.8%
- Lower volatility, beta 0.55, Low D/E 4.8%, current ratio 0.86x
- PEG 0.57 vs BAC's 0.82
- Beta 0.55 vs JPM's 0.94, lower leverage
JPM ranks third and is worth considering specifically for bank quality.
- NIM 2.2% vs BAC's 1.8%
- 20.4% margin vs DKNG's 0.9%
DKNG is the clearest fit if your priority is growth exposure.
- Rev growth 27.0%, EPS growth 99.2%, 3Y rev CAGR 39.3%
- 27.0% revenue growth vs ESCA's -4.5%
BAC is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.86, yield 2.3%
- Lower P/E (12.6x vs 122.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.0% revenue growth vs ESCA's -4.5% | |
| Value | Lower P/E (12.6x vs 122.9x) | |
| Quality / Margins | 20.4% margin vs DKNG's 0.9% | |
| Stability / Safety | Beta 0.55 vs JPM's 0.94, lower leverage | |
| Dividends | 3.2% yield, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +53.9% vs DKNG's -23.6% | |
| Efficiency (ROA) | 14.2% ROA vs BAC's 0.9%, ROIC 21.8% vs 3.5% |
ESCA vs MCRI vs JPM vs DKNG vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ESCA vs MCRI vs JPM vs DKNG vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
MCRI leads 2 • ESCA leads 0 • DKNG leads 0 • BAC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1165.8x ESCA's $240M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to DKNG's 0.9%. On growth, DKNG holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $240M | $545M | $280.3B | $6.3B | $191.6B |
| EBITDAEarnings before interest/tax | $25M | $182M | $81.4B | $313M | $40.0B |
| Net IncomeAfter-tax profit | $15M | $101M | $57.0B | $59M | $30.5B |
| Free Cash FlowCash after capex | $31M | $128M | $100.9B | $679M | $12.6B |
| Gross MarginGross profit ÷ Revenue | +27.1% | +53.0% | +60.0% | +41.8% | +56.1% |
| Operating MarginEBIT ÷ Revenue | +8.7% | +23.4% | +25.9% | +0.6% | +19.7% |
| Net MarginNet income ÷ Revenue | +6.4% | +18.6% | +20.4% | +0.9% | +15.9% |
| FCF MarginFCF ÷ Revenue | +12.7% | +23.6% | +36.0% | +10.8% | +6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.6% | +4.1% | — | +16.8% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +63.2% | -8.1% | +16.0% | +157.7% | +18.3% |
Valuation Metrics
Evenly matched — ESCA and BAC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 38% valuation discount to MCRI's 23.8x P/E. Adjusting for growth (PEG ratio), MCRI offers better value at 0.70x vs BAC's 0.95x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $256M | $2.3B | $896.0B | $14.4B | $422.8B |
| Enterprise ValueMkt cap + debt − cash | $264M | $2.2B | $1.50T | $14.7B | $556.8B |
| Trailing P/EPrice ÷ TTM EPS | 18.82x | 23.76x | 16.00x | -3580.25x | 14.66x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.25x | 19.52x | 14.40x | 122.88x | 12.56x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.70x | 0.90x | — | 0.95x |
| EV / EBITDAEnterprise value multiple | 11.11x | 11.70x | 18.36x | 56.63x | 13.92x |
| Price / SalesMarket cap ÷ Revenue | 1.07x | 4.23x | 3.20x | 2.37x | 2.21x |
| Price / BookPrice ÷ Book value/share | 1.49x | 4.50x | 2.47x | 22.77x | 1.39x |
| Price / FCFMarket cap ÷ FCF | 9.00x | 17.97x | 8.88x | 22.20x | 33.52x |
Profitability & Efficiency
MCRI leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
MCRI delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $8 for DKNG. MCRI carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to DKNG's 3.06x. On the Piotroski fundamental quality scale (0–9), ESCA scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +18.7% | +15.9% | +7.9% | +10.1% |
| ROA (TTM)Return on assets | +6.9% | +14.2% | +1.3% | +1.3% | +0.9% |
| ROICReturn on invested capital | +7.5% | +21.8% | +4.5% | -0.9% | +3.5% |
| ROCEReturn on capital employed | +9.8% | +24.7% | +8.9% | -0.6% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.11x | 0.05x | 2.60x | 3.06x | 1.21x |
| Net DebtTotal debt minus cash | $8M | -$71M | $599.0B | $330M | $134.1B |
| Cash & Equiv.Liquid assets | $12M | $96M | $343.3B | $1.6B | $231.8B |
| Total DebtShort + long-term debt | $20M | $26M | $942.4B | $1.9B | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | 37.31x | 225.55x | 0.74x | 4.48x | 0.48x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $5,729 for DKNG. Over the past 12 months, MCRI leads with a +53.9% total return vs DKNG's -23.6%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs DKNG's 4.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +38.3% | +35.0% | -0.5% | -18.7% | +1.1% |
| 1-Year ReturnPast 12 months | +33.2% | +53.9% | +21.8% | -23.6% | +28.1% |
| 3-Year ReturnCumulative with dividends | +49.9% | +91.6% | +138.2% | +13.9% | +103.0% |
| 5-Year ReturnCumulative with dividends | -8.6% | +98.1% | +118.2% | -42.7% | +47.1% |
| 10-Year ReturnCumulative with dividends | +136.9% | +515.7% | +465.8% | +195.9% | +368.2% |
| CAGR (3Y)Annualised 3-year return | +14.4% | +24.2% | +33.6% | +4.4% | +26.6% |
Risk & Volatility
MCRI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MCRI is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MCRI currently trades 98.6% from its 52-week high vs DKNG's 59.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | 0.55x | 0.94x | 0.87x | 0.86x |
| 52-Week HighHighest price in past year | $21.32 | $130.85 | $337.25 | $48.78 | $57.55 |
| 52-Week LowLowest price in past year | $11.41 | $82.18 | $262.71 | $20.46 | $43.66 |
| % of 52W HighCurrent price vs 52-week peak | +87.4% | +98.6% | +95.1% | +59.5% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 50.5 | 74.5 | 59.1 | 72.1 | 68.3 |
| Avg Volume (50D)Average daily shares traded | 35K | 136K | 7.0M | 12.1M | 31.7M |
Analyst Outlook
Evenly matched — ESCA and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ESCA as "Buy", MCRI as "Hold", JPM as "Buy", DKNG as "Buy", BAC as "Buy". Consensus price targets imply 23.3% upside for DKNG (target: $36) vs -19.0% for MCRI (target: $105). For income investors, ESCA offers the higher dividend yield at 3.21% vs MCRI's 0.91%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $104.50 | $339.75 | $35.75 | $61.13 |
| # AnalystsCovering analysts | 5 | 9 | 61 | 48 | 54 |
| Dividend YieldAnnual dividend ÷ price | +3.2% | +0.9% | +1.9% | — | +2.3% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 | — | 12 |
| Dividend / ShareAnnual DPS | $0.60 | $1.17 | $5.95 | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +3.2% | +3.9% | +5.8% | +5.1% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MCRI leads in 2 (Profitability & Efficiency, Risk & Volatility). 2 tied.
ESCA vs MCRI vs JPM vs DKNG vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ESCA or MCRI or JPM or DKNG or BAC a better buy right now?
For growth investors, DraftKings Inc.
(DKNG) is the stronger pick with 27. 0% revenue growth year-over-year, versus -4. 5% for Escalade, Incorporated (ESCA). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Escalade, Incorporated (ESCA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ESCA or MCRI or JPM or DKNG or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus Monarch Casino & Resort, Inc. at 23. 8x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Monarch Casino & Resort, Inc. wins at 0. 57x versus Bank of America Corporation's 0. 82x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ESCA or MCRI or JPM or DKNG or BAC?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -42. 7% for DraftKings Inc. (DKNG). Over 10 years, the gap is even starker: MCRI returned +515. 7% versus ESCA's +136. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ESCA or MCRI or JPM or DKNG or BAC?
By beta (market sensitivity over 5 years), Monarch Casino & Resort, Inc.
(MCRI) is the lower-risk stock at 0. 55β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 72% more volatile than MCRI relative to the S&P 500. On balance sheet safety, Monarch Casino & Resort, Inc. (MCRI) carries a lower debt/equity ratio of 5% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ESCA or MCRI or JPM or DKNG or BAC?
By revenue growth (latest reported year), DraftKings Inc.
(DKNG) is pulling ahead at 27. 0% versus -4. 5% for Escalade, Incorporated (ESCA). On earnings-per-share growth, the picture is similar: DraftKings Inc. grew EPS 99. 2% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Over a 3-year CAGR, DKNG leads at 39. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ESCA or MCRI or JPM or DKNG or BAC?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 0. 1% for DraftKings Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -0. 3% for DKNG. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ESCA or MCRI or JPM or DKNG or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Monarch Casino & Resort, Inc. (MCRI) is the more undervalued stock at a PEG of 0. 57x versus Bank of America Corporation's 0. 82x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 122. 9x for DraftKings Inc. — 110. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DKNG: 23. 3% to $35. 75.
08Which pays a better dividend — ESCA or MCRI or JPM or DKNG or BAC?
In this comparison, ESCA (3.
2% yield), BAC (2. 3% yield), JPM (1. 9% yield), MCRI (0. 9% yield) pay a dividend. DKNG does not pay a meaningful dividend and should not be held primarily for income.
09Is ESCA or MCRI or JPM or DKNG or BAC better for a retirement portfolio?
For long-horizon retirement investors, Monarch Casino & Resort, Inc.
(MCRI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 55), 0. 9% yield, +515. 7% 10Y return). Both have compounded well over 10 years (MCRI: +515. 7%, DKNG: +195. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ESCA and MCRI and JPM and DKNG and BAC?
These companies operate in different sectors (ESCA (Consumer Cyclical) and MCRI (Consumer Cyclical) and JPM (Financial Services) and DKNG (Consumer Cyclical) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ESCA is a small-cap income-oriented stock; MCRI is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; DKNG is a mid-cap high-growth stock; BAC is a large-cap deep-value stock. ESCA, MCRI, JPM, BAC pay a dividend while DKNG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.